concept

COMPLEMENT PATHWAY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about COMPLEMENT PATHWAY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

44Connections

0Hypotheses

0Analyses

39Outgoing

5Incoming

0Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	COMPLEMENT PATHWAY
Key Genes/Proteins	AMYLOID, APOE, APP, AXL, CD68, CSF1R
Related Diseases	ALZHEIMER, CSF, CYTOKINES, DEMENTIA, GLAUCOMA

Pathway Diagram

graph TD
    COMPLEMENT_PATHWAY[COMPLEMENT PATHWAY]
    COMPLEMENT_PATHWAY -->|promotes| Phagoptosis[Phagoptosis]
    COMPLEMENT_PATHWAY -->|involved_in| Multiple_Sclerosis[Multiple Sclerosis]
    COMPLEMENT_PATHWAY -->|interacts| NLRP3_Inflammasome_Activation[NLRP3 Inflammasome Activation]
    COMPLEMENT_PATHWAY -->|interacts| Nlrp3_Inflammasome_Signaling[Nlrp3 Inflammasome Signaling]
    COMPLEMENT_PATHWAY -->|modulates| Synaptic_Function[Synaptic Function]
    COMPLEMENT_PATHWAY -->|mediates| Retinal_Degeneration[Retinal Degeneration]
    COMPLEMENT_PATHWAY -->|degrades| TNF[TNF]
    COMPLEMENT_PATHWAY -->|activates| MICROGLIA[MICROGLIA]
    COMPLEMENT_PATHWAY -->|interacts| MULTIPLE_SCLEROSIS[MULTIPLE SCLEROSIS]
    CLU[CLU] -->|component_of| COMPLEMENT_PATHWAY
    CSF1R[CSF1R] -->|inhibits| COMPLEMENT_PATHWAY
    AMYLOID[AMYLOID] -->|interacts| COMPLEMENT_PATHWAY

Outgoing (39)

Target	Relation	Type	Str
Multiple Sclerosis	involved_in	disease	0.85
Phagoptosis	promotes	process	0.85
NLRP3 Inflammasome Activation	interacts_with	process	0.82
Nlrp3 Inflammasome Signaling	interacts_with	pathway	0.80
Retinal Degeneration	mediates	process	0.75
Synaptic Function	modulates	process	0.75
Alzheimer's disease	associated_with	disease	0.70
MICROGLIA	activates	cell_type	0.70
TNF	degrades	gene	0.70
TNF	interacts_with	gene	0.70
SYNAPTIC LOSS	causes	phenotype	0.65
MULTIPLE SCLEROSIS	interacts_with	disease	0.65
NEUROINFLAMMATION	causes	phenotype	0.65
MICROGLIA	associated_with	cell_type	0.50
DEMENTIA	associated_with	disease	0.50
AMYLOID	associated_with	protein	0.50
ASTROCYTE	associated_with	cell_type	0.50
CYTOKINES	associated_with	phenotype	0.50
INFLAMMATION	associated_with	phenotype	0.50
TNF	associated_with	gene	0.50
TREM2	associated_with	gene	0.50
CSF1R	associated_with	gene	0.50
CX3CR1	associated_with	gene	0.50
P2RY12	associated_with	gene	0.50
APOE	associated_with	gene	0.50
CSF	associated_with	phenotype	0.50
SENESCENCE	associated_with	phenotype	0.50
ASTROCYTES	associated_with	cell_type	0.50
CD68	associated_with	gene	0.45
NEURODEGENERATION	associated_with	phenotype	0.45
NEURON	associated_with	cell_type	0.45
ALZHEIMER	associated_with	disease	0.45
SYNAPTIC LOSS	associated_with	phenotype	0.45
GLAUCOMA	associated_with	disease	0.45
NEUROINFLAMMATION	associated_with	phenotype	0.45
AXL	associated_with	gene	0.45
DENTATE GYRUS	associated_with	brain_region	0.45
APP	associated_with	gene	0.45
MERTK	associated_with	gene	0.45

Incoming (5)

Source	Relation	Type	Str
CLU	component_of	gene	0.85
AMYLOID	interacts_with	protein	0.70
AMYLOID	activates	protein	0.70
CSF1R	inhibits	gene	0.70
MULTIPLE SCLEROSIS	associated_with	disease	0.45

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning COMPLEMENT PATHWAY in their description or question text

No additional research found